Cantitate/Preț
Produs

Textbook of Clinical Management of Club Drugs and Novel Psychoactive Substances: NEPTUNE Clinical Guidance

Autor Dima Abdulrahim, Owen Bowden-Jones
en Limba Engleză Paperback – 12 oct 2022
There are global concerns about the proliferation and misuse of club drugs and novel psychoactive substances, yet we know little about their harms and research on clinical management and treatment remains limited. This book fills the knowledge gap by providing a detailed overview of the research evidence available to date. The book provides a framework that allows readers to understand this large number of new drugs, using classifications based on primary psychoactive effect. Within this framework, the book provides detailed reviews of the more commonly used drugs. Each chapter explores pharmacology, patterns and mode of use, acute and chronic harms, and clinical interventions supported by research evidence. An invaluable resource for clinical staff, this book will support clinicians working in the emergency department, substance misuse and addiction services, mental health services, primary care, sexual health services and more. It will also be of interest to academics and those developing drug policy.
Citește tot Restrânge

Preț: 48753 lei

Preț vechi: 51319 lei
-5% Nou

Puncte Express: 731

Preț estimativ în valută:
9331 9843$ 7776£

Carte tipărită la comandă

Livrare economică 02-16 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781009182133
ISBN-10: 1009182137
Pagini: 384
Dimensiuni: 187 x 245 x 18 mm
Greutate: 0.62 kg
Ediția:Nouă
Editura: Cambridge University Press
Colecția Cambridge University Press
Locul publicării:Cambridge, United Kingdom

Cuprins

1. An Introduction to Club Drugs and Novel psychoactive substances; 2. Psychosocial interventions for club drugs and novel psychoactive substances; 3. Gamma-hydroxybutyrate (GHB) and gamma-butyrolactone (GBL) Drug group: depressants; 4. New Benzodiazepine (BZD) NPS; 5. Synthetic Opioids NPS (fentanyl and non-fentanyl NPS); 6. Ketamine and other NPS with dissociative effects; 7. Nitrous oxide (N2O); 8. Stimulant Club Drugs and novel psychoactive substances; 9. 'Ecstasy'- MDMA, 3,4-methylenedioxymethamphetamine), MDMA analogues and drugs with similar effects; 10 . Methamphetamine; 11. Synthetic cathinones; 12. Hallucinogenic drugs; 13. Synthetic cannabinoid receptor agonists (SCRA).

Recenzii

'This book is a welcome addition to the previous 2015 NEPTUNE guidance. It provides a unique learning experience on what all clinicians should know about the misuse of club drugs and novel psychoactive substances. Capturing the latest trends of a dynamic drug market, the authors pulled together the best available evidence on a variety of substances to support the improvement of clinical practice. Whether you consult chapters of special interest or read the entire book, you can be assured that you will have been exposed to the most comprehensive work available on the clinical management of the harms of novel psychoactive substances. Highly recommended.' Ornella Corazza, Ph.D., Professor of Addiction Science, University of Hertfordshire, UK, and President of the International Society for the Study of Emerging Drugs
'The reader is here provided with unique, clear information on the treatment/management of NPS/club drug intake.' Fabrizio Schifano, University of Hertfordshire, UK

Notă biografică


Descriere

The only book to present the international evidence on harms and clinical management of club drugs and novel psychoactive substances.